首页> The American heart journal> Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY beta-blocker Administration before primary PCI in patients with ST-elevation Myocardial Infarction trial

Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY beta-blocker Administration before primary PCI in patients with ST-elevation Myocardial Infarction trial

导出原文传递

翻译打印收藏纠错

第一作者： Roolvink, Vincent

作者： Roolvink, Vincent ^[1] ; Rasoul, Saman ^[2] ; Ottervanger, Jan Paul ^[3] ; Dambrink, Jan-Henk E. ^[4] ; Lipsic, Erik ^[5] ; van der Horst, Iwan C. C. ^[6] ; de Smet, Bart ^[7] ; Kedhi, Elvin ; Gosselink, A. T. Marcel ; Piek, Jan J. ; Sanchez-Brunete, Vicente ; Ibanez, Borja ; Fuster, Valentin ; van't Hof, Arnoud W. J.

作者单位： Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands ^[1] Serv Urgencia Med Madrid SUMMA 112, Madrid, Spain ^[2] Ctr Nacl Invest Cardiovasc, Madrid, Spain ^[3] Acad Med Ctr, Dept Cardiol, Amersfoort, Netherlands ^[4] Isala Klin, Dept Cardiol, NL-8025 AB Zwolle, Netherlands ^[5] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands ^[6] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands ^[7]

发布时间 2015-05-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交